Company intelligence / Profile preview

KD Secure

Salem, New Hampshire, USA

Ownership: Private
Development stage: Other

Overview

KD Secure was a biosecurity technology company that developed a proprietary pattern recognition engine used to screen synthetic DNA sequences. The company's software became the industry standard for the International Gene Synthesis Consortium (IGSC), allowing manufacturers to identify potential biothreats by matching orders against databases of regulated pathogens. Originally founded to provide video analytics, KD Secure successfully adapted its algorithms for the life sciences sector before its biosecurity assets and leadership were integrated into Gen9, a synthetic DNA manufacturer later acquired by Ginkgo Bioworks.

Therapeutic areas: Infectious Diseases
Modalities: Synthetic DNA
Industry: Non-Drug Biotech

Partnerships

International Gene Synthesis Consortium (IGSC)

Beyond the preview

Go deeper on KD Secure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KD Secure.

Explore the full profile